CATHERINE YUEN: Open Payments
NPI 1275107369 · BEVERLY HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$76 in 4 payments from 4 companies in 2025. Trend: 2023 $858 · 2024 $181 · 2025 $76
Food & beverage: $76
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 1 | $29 |
| Gilead Sciences, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $14 |
| Solventum Corporation | 1 | $14 |
Products named: MOUNJARO, Wegovy, ACTIV.A.C..
Industry payments across CA — which companies pay providers there.
